top of page

News and Presentations 

​Tue, 30 Sep 2025 10:17:17 EDT - EVMS News 

Academy Honors Dr. Milton Brown for Scientific Excellence
Article Link

​

Tue, 26 May 2026 

Kumar, V.P., Kong, Y., Wang, K. et al. YK-4–250 mitigates gastrointestinal radiation syndrome and promotes overall survival following partial body radiation injury. Sci Rep 16, 23964 (2026). https://doi.org/10.1038/s41598-026-53734-7

Article Link
 

Mon, 6 Jul 2026 
Nyalwidhe JO, Kumar VP, Chen S, Lockett J, Kong Y, Ghosh SP, Mu D, Brown ML. Pharmacokinetic Characterization of the Gastrointestinal Acute Radiation Syndrome Mitigator YK-4-250 in Male and Female Mice Under Non-Irradiated and Partial Body Irradiation Conditions. Res Sq [Preprint]. 2026 Jul 6:rs.3.rs-10022093. doi: 10.21203/rs.3.rs-10022093/v1. PMID: 42466404; PMCID: PMC13370642.
Article Link


Tue, 1 Sep 2026 

Friedrich S, Kong Y, Musayev FN, Brown ML, Gupton BF. YK-4-250, a synthetic telmisartan-tempol conjugate: crystal structure of a stabilized free radical containing an angiotensin AT1 receptor inhibitor. Acta Crystallogr C Struct Chem. 2026 Sep 1. doi: 10.1107/S2053229626007242. Epub ahead of print. PMID: 42611622.

Article Link

 

Mon, 21 Jul 2025 

​DiCarlo A, Button J, Cassatt D, Chang A, Finklea L, Iyer N, Moroni M, Rios C, Rudokas M, Satyamitra M, Taliaferro L, Winters T, Homer M. Advanced Medical Countermeasures and Devices for Use During a Radiological or Nuclear Emergency. Disaster Med Public Health Prep. 2025 Jul 21;19:e199. doi: 10.1017/dmp.2025.12. PMID: 40686053; PMCID: PMC12313093.
Article Link

 

10, April 2024
​The Future of Radiological and Nuclear (RN) Defense Programs and Capabilities 
David A. Schauer, Armed Forces Radiobiology Research
Article Link

© 2025 by Trocar Pharma Inc.

bottom of page